Personal statement
Our work aims to understand the tumour biology of brain and ovarian cancers, which will help us identify novel treatments resulting in improved patient outcomes. We pursue this by developing experimental models of disease that recapitulate the clinical environment, including three-dimensional cell culture systems using scaffolds, organoid and ex-vivo models and in vivo models of disease.
Professional activities
- ESTRO - Radiobiology Workshop
- Participant
- 7/10/2022
- Modelling glioblastoma responses to drug-radiation combination treatments
- Speaker
- 18/7/2022
- Modelling treatment response of drug-radiation combinations in glioblastoma
- Speaker
- 22/6/2022
- CRISPR in Radiation Research Workshop
- Participant
- 14/6/2022
- The Journal of Pathology Clinical Research (Journal)
- Peer reviewer
- 1/5/2022
- Gliomodel (External organisation)
- Advisor
- 1/4/2022
More professional activities
Projects
- BRAINS Strathclyde Centre for Doctoral Training
- MacKenzie, Lewis (Principal Investigator) Childs, Peter (Principal Investigator) Witte, Kimia (Principal Investigator) Jimenez, Melanie (Principal Investigator) Chow, Shiao (Principal Investigator) Fu, Ying (Principal Investigator) Gomez-Roman, Natividad (Principal Investigator) Fazio, Mariana (Principal Investigator) Reid, Andrew Baxter (Principal Investigator)
- Centre for Doctoral Training in Bridging Research and Advancements in Neurological Sciences (BRAINS). First cohort of PhD students starting autumn 2023.
- 01-Jan-2023
- Developing Aberdeen's Cancer Research Network
- Spiers, Valerie (Principal Investigator) kiltie, anne (Principal Investigator) Gomez-Roman, Natividad (Co-investigator) Boyd, Marie (Co-investigator) Tomlinson, Ian P M (Principal Investigator) Gourley, Charlie (Co-investigator) Machesky, Laura (Co-investigator) Chalmers, Anthony (Principal Investigator) Broche, Lionel (Co-investigator) Stansfield, Ian (Co-investigator)
- The aim of this proposal is to encourage new collaborative research and innovation in these fields, through working with colleagues in the CRUK Scotland Centre based in Edinburgh and Glasgow, broadening the range of cancer research being conducted in Scotland.
- 01-Jan-2022 - 30-Jan-2023
- Investigating Novel Wee1 and Chk1 Inhibitors with Improved Brain Permeability for the Treatment of Glioblastoma
- Gomez-Roman, Natividad (Principal Investigator)
- SULSA-industrial collaboration evaluating novel brain permeable compounds in 3D glioblastoma model systems
- 01-Jan-2022 - 31-Jan-2023
- Understanding the role of cholesterol in the survival and treatment resistance of glioblastoma and its feasibility as a druggable target
- Gomez-Roman, Natividad (Principal Investigator) Morgan, John (Post Grad Student)
- 01-Jan-2021 - 30-Jan-2024
- Developing more representative laboratory models of the blood-tumour barrier to improve the drug development pipeline for patients with glioblastoma.
- Chalmers, Anthony (Principal Investigator) Carruthers, Ross D (Co-investigator) Birch, Joanna (Co-investigator) Smith, Colin (Co-investigator) Ireson, Chistopher (Co-investigator) Brennan, Paul (Co-investigator) Thompson, Gerry (Co-investigator) Gomez-Roman, Natividad (CoI) Salmeron-Sanchez, Manuel (CoI) Brunton, Val (CoI)
- 01-Jan-2021 - 31-Jan-2024
- Investigating cholesterol protection to radiation treatment in glioblastoma
- Gomez-Roman, Natividad (Principal Investigator)
- 01-Jan-2021 - 31-Jan-2023
More projects
Address
Strathclyde Institute of Pharmacy and Biomedical Sciences
Hamnett Wing
Hamnett Wing
Location Map
View
University of Strathclyde
in a larger map